Cliftonlarsonallen Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

Cliftonlarsonallen Wealth Advisors, LLC

$4.33 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$40.25 - $52.99 $2,415 - $3,179	-60 Reduced 0.59%	10,122 $420,000
Q1 2024 May 02, 2024	SELL	$47.98 - $54.4 $40,783 - $46,240	-850 Reduced 7.7%	10,182 $552,000
Q4 2023 Jan 16, 2024	SELL	$48.48 - $57.85 $17,598 - $20,999	-363 Reduced 3.19%	11,032 $566,000
Q3 2023 Oct 13, 2023	BUY	$57.89 - $64.73 $5,267 - $5,890	91 Added 0.81%	11,395 $661,000
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $17,520 - $19,453	-275 Reduced 2.37%	11,304 $722,000
Q1 2023 Apr 12, 2023	SELL	$65.71 - $74.53 $39,754 - $45,090	-605 Reduced 4.97%	11,579 $802,000
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $12,463 - $14,758	-182 Reduced 1.47%	12,184 $0
Q3 2022 Oct 12, 2022	BUY	$0.13 - $76.84 $33 - $20,055	261 Added 2.16%	12,366 $879,000
Q2 2022 Jul 08, 2022	BUY	$72.62 - $79.98 $72 - $79	1 Added 0.01%	12,105 $932,000
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $39,408 - $47,254	641 Added 5.59%	12,104 $884,000
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $8,634 - $10,065	-161 Reduced 1.39%	11,463 $715,000
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $687,792 - $805,659	11,624 New	11,624 $688,000
Q3 2021 Oct 14, 2021	SELL	$59.17 - $69.31 $707,377 - $828,601	-11,955 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $1,238 - $1,348	20 Added 0.17%	11,955 $799,000
Q1 2021 May 24, 2021	SELL	$59.34 - $66.74 $87,823 - $98,775	-1,480 Reduced 11.03%	11,935 $753,000
Q4 2020 Jan 14, 2021	BUY	$57.74 - $65.43 $7,217 - $8,178	125 Added 0.94%	13,415 $832,000
Q3 2020 Oct 13, 2020	SELL	$57.43 - $63.64 $16,597 - $18,391	-289 Reduced 2.13%	13,290 $801,000
Q2 2020 Jul 16, 2020	BUY	$54.82 - $64.09 $69,073 - $80,753	1,260 Added 10.23%	13,579 $798,000
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $37,448 - $48,848	761 Added 6.58%	12,319 $791,000
Q3 2019 Oct 07, 2019	BUY	$42.77 - $50.71 $494,335 - $586,106	11,558 New	11,558 $586,000
Q1 2019 Apr 09, 2019	SELL	$45.12 - $53.8 $1.25 Million - $1.49 Million	-27,634 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$48.76 - $63.23 $216,445 - $280,677	4,439 Added 19.14%	27,634 $1.44 Million
Q3 2018 Nov 05, 2018	SELL	$55.19 - $62.25 $21,579 - $24,339	-391 Reduced 1.66%	23,195 $1.44 Million
Q2 2018 Jul 23, 2018	BUY	$50.53 - $62.98 $3,031 - $3,778	60 Added 0.26%	23,586 $1.31 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $1.3 Million - $1.5 Million	23,526	23,526 $1.5 Million

Others Institutions Holding BMY

# of Institutions

2,532

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cliftonlarsonallen Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cliftonlarsonallen Wealth Advisors, LLC with notifications on news.

Account